InfuSystem Holdings (INFU) Cash from Financing Activities (2010 - 2026)

InfuSystem Holdings (INFU) posted Cash from Financing Activities of -$790000.0 for Q1 2026, up 70.77% on a QoQ basis from -$2.7 million in Q4 2025, and down 142.47% year-over-year from $1.9 million in Q1 2025.

InfuSystem Holdings (INFU) Cash from Financing Activities (2010 - 2026) Analysis & Trends

InfuSystem Holdings' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$790000.0 for Q1 2026.

  • Quarterly Cash from Financing Activities fell 142.47% year-over-year to -$790000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.6 million (down 209.15% YoY) and the FY2025 annual result came in at -$15.0 million, down 116.05% from the prior year.
  • Cash from Financing Activities was -$790000.0 for Q1 2026 at InfuSystem Holdings, up from -$2.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $3.7 million in Q2 2024 and bottomed at -$8.0 million in Q3 2025.
  • A 5-year average of -$2.0 million and a median of -$1.7 million in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 4117.35% — and 2024, when it surged 1679.15%.
  • InfuSystem Holdings' Cash from Financing Activities stood at -$1.7 million in 2022, then sank by 107.01% to -$3.5 million in 2023, then declined by 27.4% to -$4.5 million in 2024, then surged by 40.13% to -$2.7 million in 2025, then surged by 70.77% to -$790000.0 in 2026.
  • Business Quant data shows INFU's Cash from Financing Activities at -$790000.0 in Q1 2026, -$2.7 million in Q4 2025, and -$8.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InfuSystem Holdings 179.47 Mn 177.37 Mn 19.68 Mn -790,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -790,000.00
Mar 31, 2026 -790,000.00
Dec 31, 2025 -2.70 Mn
Dec 31, 2025 -2.70 Mn
Sep 30, 2025 -8.01 Mn
Sep 30, 2025 -8.01 Mn
Jun 30, 2025 -6.11 Mn
Jun 30, 2025 -6.11 Mn
Mar 31, 2025 1.86 Mn
Mar 31, 2025 1.86 Mn
Dec 31, 2024 -4.52 Mn
Dec 31, 2024 -4.52 Mn
Sep 30, 2024 -6.75 Mn
Sep 30, 2024 -6.75 Mn
Jun 30, 2024 3.71 Mn
Jun 30, 2024 3.71 Mn
Mar 31, 2024 632,000.00
Mar 31, 2024 632,000.00
Dec 31, 2023 -3.54 Mn
Dec 31, 2023 -3.54 Mn